What's Ted Ebel's mailing address?
Ted's mailing address filed with the SEC is 200 CARDINAL WAY, 2ND FLOOR, , REDWOOD CITY, CA, 94063.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Menlo Therapeutics
Over the last 7 years, insiders at Menlo Therapeutics have traded over $3,825,000 worth of Menlo Therapeutics stock and bought 3,655,938 units worth $21,205,011 . The most active insiders traders include Advisors Llcperceptive Life..., Llc Fmr, and Albert Cha. On average, Menlo Therapeutics executives and independent directors trade stock every 85 days with the average trade being worth of $572,944. The most recent stock trade was executed by Sharon Barbari on 20 August 2020, trading 75,000 units of MNLO stock currently worth $111,000.
What does Menlo Therapeutics do?
Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Redwood City, CA.
What does Menlo Therapeutics's logo look like?
Menlo Therapeutics executives and stock owners
Menlo Therapeutics executives and other stock owners filed with the SEC include:
-
Elisabeth Sandoval,
Independent Director -
Patrick LePore,
Independent Director -
Anthony Bruno,
Director -
Rex Bright,
Director -
Sharon Barbari,
Director -
Matthew Wiley,
Chief Commercial Officer -
Mutya Harsch,
Chief Legal Officer, General Counsel -
Ronald Krasnow,
Chief Compliance Officer -
Iain Stuart,
Chief Scientific Officer -
Andrew Saik,
Chief Financial Officer, Treasurer -
David Domzalski,
Chief Executive Officer, Director -
Steven L Basta,
Director -
Advisors Llcperceptive Life...,
-
Ilan Hadar,
CFO and Country Manager -
Stanley Hirsch,
Director -
Partners 2007 Gp, L.P.Presi...,
-
Global Strategic Fund Ii L....,
10% owner -
Ventures Llc Remeditex,
10% owner -
Capital Viii, Llc Vivo Capi...,
-
Albert Cha,
Director -
Llc Fmr,
-
Scott M Whitcup,
Director -
Mary Spellman,
Chief Medical Officer -
Kristine M Ball,
See Remarks -
David W J Mcgirr,
Director -
Paul L Berns,
Director -
Ted Ebel,
Director -
Aaron Royston,
Director -
Paul Kwon,
Chief Scientific Officer